Evidence map›Paper›PMID 31467536›Full record

ArticleJournal of oncology2019

Polymorphisms in Survivin (

Ilona Sušac, Petar Ozretić, Maja Gregorić, Mirela Levačić Cvok, Maja Sabol, Sonja Levanat, Diana Trnski, Domagoj Eljuga, Sven Seiwerth, Gorana Aralica and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Genetic Variants inGenes · 2025
    Article
  4. Article
  5. International journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Evidence for familial clustering in breast cancer age of onset.International journal of epidemiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ilona SušacEljuga Polyclinic, 10000 Zagreb, Croatia.
Petar OzretićDivision of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.ORCID https://orcid.org/0000-0001-9757-6636
Maja GregorićZagreb Health School, 10000 Zagreb, Croatia.
Mirela Levačić CvokDivision of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Maja SabolDivision of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Sonja LevanatDivision of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Diana TrnskiDivision of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Domagoj EljugaEljuga Polyclinic, 10000 Zagreb, Croatia.
Sven SeiwerthInstitute of Pathology, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Gorana AralicaInstitute of Pathology, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Mladen StanecDepartment for Oncoplastic and Reconstructive Surgery, University Hospital for Tumors, 10000 Zagreb, Croatia.
Vesna MusaniDivision of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.ORCID https://orcid.org/0000-0001-9927-3727
Ruđer Bošković Institute · HRUniversity Hospital Centre Zagreb · HRUniversity of Zagreb · HRZagreb School of Business · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Survivin, encoded by

Identifiers

PMID31467536
PMCPMC6699404
OpenAlexW2965264177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.